Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 2/20 | 0.39 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.39 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.35 |
| ▸ | MALT1 | Q9UDY8 | 4/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30070407 | 0.90 | ALDH1A1 (0.44) | LIMK1LIMK2SMARCA2MALT1TRPV1 | |
| SCHEMBL4072179 | 0.90 | ALDH1A1 (0.44) | LIMK1LIMK2SMARCA2MALT1TRPV1 | |
| SCHEMBL15775839 | 0.89 | SCN9A (0.39) | LIMK1LIMK2SMARCA2MALT1TRPV1 | |
| SCHEMBL14698494 | 0.84 | HSD11B1 (0.40) | TRPV1TRPA1 | |
| SCHEMBL25275622 | 0.83 | ALDH1A1 (0.44) | LIMK1LIMK2 | |
| SCHEMBL30466605 | 0.83 | ALDH1A1 (0.44) | LIMK1LIMK2 | |
| SCHEMBL14234689 | 0.82 | TRPA1 (0.38) | MALT1TRPV1TRPA1 | |
| SCHEMBL29558552 | 0.82 | TRPA1 (0.38) | MALT1TRPV1TRPA1 | |
| SCHEMBL28812160 | 0.81 | TRPA1 (0.37) | MALT1TRPV1TRPA1 | |
| SCHEMBL590879 | 0.80 | DHODH (0.41) | MALT1TRPV1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9556141-B2 | Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof | BASF SE (DE) | 2017-01-31 | — | — | US | disclosed |
| EP-2782910-B1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLATE COMPOUNDS AND DERIVATIVES THEREOF | BASF SE (DE) | 2016-02-03 | — | — | EP | disclosed |
| US-20150087843-A1 | Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof | BASF SE (DE) | 2015-03-26 | — | — | US | disclosed |
| US-8921567-B2 | Process for preparing N-substituted 1H-pyrazole-5-carbonylchloride compounds | BASF SE (DE) | 2014-12-30 | — | — | US | disclosed |
| EP-2782910-A1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLATE COMPOUNDS AND DERIVATIVES THEREOF | BASF SE (DE) | 2014-10-01 | — | — | EP | disclosed |
| WO-2014128136-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-08-28 | — | — | WO | disclosed |
| US-20140179519-A1 | N-THIO-ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-26 | — | — | US | disclosed |
| EP-2742036-A1 | N-THIO-ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-18 | — | — | EP | disclosed |
| EP-2742035-A1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBONYLCHLORIDE COMPOUNDS | BASF SE (DE) | 2014-06-18 | — | — | EP | disclosed |
| US-20140163234-A1 | Process for preparing N-substituted 1H-pyrazole-5-carbonylchloride compounds | BASF SE (DE) | 2014-06-12 | — | — | US | disclosed |
| CN-103827103-A | N-thio-anthranilamide compounds and their use as pesticides | BASF SE | 2014-05-28 | — | — | CN | disclosed |
| WO-2013076092-A1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLATE COMPOUNDS AND DERIVATIVES THEREOF | BASF SE (DE) | 2013-05-30 | — | — | WO | disclosed |
| WO-2013024010-A1 | N-THIO-ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2013-02-21 | — | — | WO | disclosed |
| WO-2013024007-A1 | PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBONYLCHLORIDE COMPOUNDS | BASF SE (DE) | 2013-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179519-A1 | N-THIO-ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | NAT1, ANTXR2, ATL3 | LIMK1 4327/4885LIMK2 4106/4885SMARCA2 4482/4885 |
| US-20150087843-A1 | Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof | CA5B, CA5A, PC | LIMK1 2238/4885LIMK2 2709/4885SMARCA2 2982/4885 |
| US-20140163234-A1 | Process for preparing N-substituted 1H-pyrazole-5-carbonylchloride compounds | CDK13, C5, C9 | LIMK1 2227/4885LIMK2 1898/4885SMARCA2 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.